Cost-Effectiveness Analysis of Bimekizumab against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan
{{output}}
Introduction: Psoriasis is a chronic, inflammatory skin disease that significantly impairs patients' quality of life (QOL). Several biologics with varying mechanisms of action are approved for treating moderate-to-severe plaque ... ...